Test, author [ref] and year | Sample size | Sensitivity/specificity | LR+/LR− | QUADAS score | Criterion standard |
Neer test | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 86/49 | 1.69/0.29 | |||
Stage I–III | 68/69 | 2.17/0.47 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 71/31 | 1.02/0.94 | |||
Stage I–III | 89/31 | 1.28/0.37 | |||
MacDonald et al22 2000 | 85 subjects | 8 | Surgery | ||
Stage I | 75/48 | 1.41/0.55 | |||
Stage I–III | 77/63 | 2.05/0.37 | |||
Bak & Fauno24 1997 | 72 shoulders | 7 | Surgery | ||
Stages I–III | 39/98 | 19.5/0.62 | |||
Leroux et al26 1995 | 55 patients | ||||
Stages I–III | 89/NR | NR/NR | 10 | Surgery | |
Hawkins−Kennedy test | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 76/45 | 1.36/0.55 | |||
Stage I–III | 72/66 | 2.12/0.33 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 95/31 | 1.38/0.16 | |||
Stage I–III | 92/25 | 1.23/0.32 | |||
MacDonald et al22 2000 | 85 subjects | 8 | Surgery | ||
Stage I | 92/44 | 1.65/0.19 | |||
Stages I–III | 89/60 | 2.23/0.18 | |||
Bak & Fauno24 1997 | 72 shoulders | 7 | Surgery | ||
Stages I–III | 80/78 | 3.62/0.26 | |||
Leroux et al26 1995 | 55 patients | 10 | Surgery | ||
Stages I–III | 87/NR | NR/NR | |||
Painful arc | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 71/47 | 1.33/0.63 | |||
Stage I–III | 74/81 | 3.89/0.33 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 10/88 | 44/1.02 | |||
Stage I–III | 33/81 | 1.67/0.84 | |||
Cross-body adduction | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 25/80 | 1.25/0.94 | |||
Stage I–III | 23/82 | 1.25/0.95 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 62/31 | 0.90/1.23 | |||
Stage I–III | 82/28 | 1.13/0.65 | |||
Speed test | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 33/70 | 1.10/0.96 | |||
Stage I–III | 38/83 | 2.29/0.74 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 52/58 | 1.24/0.83 | |||
Stage I–III | 69/56 | 1.54/0.57 | |||
Drop arm | |||||
Park et al25 2005 | 552 subjects | 10 | Surgery | ||
Stage I | 14/77 | 61/1.12 | |||
Stage I–III | 27/88 | 2.25/0.83 | |||
Calis et al21 2000 | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 4/100 | NR/NR | |||
Stage I–III | 8/97 | 2.79/0.95 | |||
Other tests | |||||
Park et al25 2005 − supraspinatus/empty can | 552 subjects | 10 | Surgery | ||
Stage I | 25/67 | 76/1.12 | |||
Stage I–III | 44/90 | 4.4/0.62 | |||
Park et al25 2005 − infraspinatus test | 552 subjects | 10 | Surgery | ||
Stage I | 25/69 | 0.81/1.09 | |||
Stage I–III | 42/90 | 4.2/0.64 | |||
Calis et al212000 − Yergason test | 125 shoulders | 8 | Subacromial injection & MRI | ||
Stage I | 10/88 | 0.45/1.02 | |||
Stage I–III | 37/86 | 2.7/0.73 | |||
Zaslav23 2001 − internal rotation resistance strength, non-subacromial and impingement tests | 110 subjects | 88/96 | 25/0.12 | 8 | Surgery |
Leroux et al26 1995 − Yocum testStages I–III | 55 patients | 78/NR | NR/NR | 10 | Surgery |
NR, not reported or unable to be calculated based on the article examined.
Stage I: impingements I = tendonitis or bursitis.
Stage II: impingement stage II = partial rotator cuff tear.
Stage III: impingement stage III = full or complete rotator cuff tear.
Where possible for tables 3–7, 2×2 tables were reconstructed and 0.5 was added to any cell with 0 subjects. Sensitivity = true positives/(true positives + false negatives). Specificity = true negatives/(true negatives + false positives). Positive likelihood ratios indicated by LR+ = sensitivity/(1 − specificity). Negative likelihood ratios indicated by LR− = (1 − sensitivity)/specificity.